Diyong Xu

Insider Reports History

Entity
Individual
Location
601 Lexington Ave., 54 Th Floor, New York, NY
Signature
/s/ Eric Bell, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Diyong Xu:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Homology Medicines, Inc. Director, 10%+ Owner Common Stock 2.25M $1.29M $0.57 Mar 25, 2024 By OrbiMed Private Investments VII, LP
Homology Medicines, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 12.8K $171K $13.42 Mar 25, 2024 Direct

Insider Reports Filed by Diyong Xu

Symbol Company Period Transactions Value $ Form Type Date Filed Role
QTTB Homology Medicines, Inc. Mar 25, 2024 1 $0 4 Mar 27, 2024 Director, 10%+ Owner
QTTB Homology Medicines, Inc. Mar 25, 2024 0 $0 3 Mar 27, 2024 Director, 10%+ Owner